查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
自動體外心臟去顫器市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品類型、最終用戶、地區、競爭細分
市場調查報告書
商品編碼
1355174

自動體外心臟去顫器市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品類型、最終用戶、地區、競爭細分

Automated External Defibrillator Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Product Type, By End User, By Region, Competition
出版日期: | 出版商: TechSci Research | 英文 200 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年全球自動體外心臟去顫器市場價值為32.152 億美元，預計在預測期內將呈現強勁成長，到2028 年複合年成長率為7.0%。除顫器作為醫療設備，用於對患者進行電擊或脈衝治療。心臟以恢復正常的心跳。它們用於預防或治療異常、緩慢或快速的心律，稱為心律不整。此外，除顫器可以使突然停止跳動的心臟恢復活力。除顫器存在多種設計和操作方法。自動體外心臟去顫器 (AED) 在公共場所隨處可見，未經訓練的個人也可以在緊急情況下使用，從而有可能挽救心臟驟停的患者。其他類型的除顫器，例如穿戴式式心律轉復除顫器 (WCD) 和植入式心律轉復除顫器 (ICD)，可用於預防危及生命的心律不整高風險個體的猝死。適應在家中使用除顫器可能需要時間和精力，因此意識到潛在問題至關重要。

主要市場促進因素：

心血管疾病的發生率不斷上升

市場概況
預測期 2018-2028
2022 年市場規模 150001萬美元
2028 年市場規模 225485萬美元
2023-2028 年複合年成長率 7.04%
成長最快的細分市場 全自動體外心臟去顫器
最大的市場 北美洲

儘管緊急心臟護理的進步提高了患者的生存機會，但心血管疾病的流行仍然是全球死亡的重要原因。研究表明，每年約有 35 萬名美國人死於心臟病，其中一半是在醫療機構之外因心臟停止功能而意外死亡的。突發性心臟驟停是這些早死的原因之一。心室顫動是一種心律不整疾病，通常會引發心臟驟停。自動體外心臟去顫器 (AED) 因其能夠透過電擊治療異常心律而越來越受歡迎。這些設備旨在檢測和治療兩種特定類型的心律不整：無脈性室性心動過速和心室顫動。未來幾年，隨著擴大使用這些設備來治療心臟驟停的患者，全球 AED 市場預計將帶來創收機會。此外，越來越多的人依賴吸煙和飲酒可能有助於繁榮的市場前景。

先進除顫器設備的採用率增加

先進除顫器設備的採用顯著增加。這些現代設備配備了方便用戶使用的介面和自動化功能，使更廣泛的醫療保健專業人員（包括非專家）可以使用它們。這種可訪問性在緊急情況下非常有用，可以自信地操作這些設備，改善患者護理和治療結果。隨著已開發國家和發展中國家的醫療支出持續成長，用於升級醫療設備和技術的投資不斷增加。為此，醫院和醫療機構正在優先考慮使用先進的除顫器，以滿足老年患者的獨特需求並提供最佳護理。

對優質醫療服務的需求也不斷上升。及時的醫療干預至關重要，尤其是在心臟驟停等危急情況下。除顫器在快速應對危及生命的心律不整方面發揮著至關重要的作用，可顯著提高成功復甦的機會和更好的患者預後。透過優質照護協議優先考慮醫療機構、公共場所甚至家庭中除顫器的可用性和正確使用，從而提高生存率。透過迅速恢復正常心律，除顫器有助於改善患者預後並減少長期健康後果。對優質護理的關注不僅提高了患者的體驗和滿意度，而且還推動了對先進除顫器技術的投資。

主要市場趨勢

下一代除顫器的進步

由於下一代除顫器的進步，除顫器市場預計將加速成長，超出最初的預期。除顫器在識別和解決設備相關問題方面發揮著至關重要的作用。心臟驟停 (SCA) 是全球死亡的主要原因，具有潛在的死亡風險。然而，早期介入和除顫可以有效地控制這種情況。在體外去顫器中，自動體外心臟去顫器 (AED) 佔據市場主導地位，並且由於越來越多的心臟衰竭患者依賴它們，預計將出現顯著擴張。不斷成長的需求與更廣泛的 AED 的可用性一致。目前，穿戴式裝置比手動體外心臟去顫器具有競爭優勢。此外，預計未來幾年市場成長將受到皮下植入式心臟復律去顫器(S-ICD)、MRI 相容植入式心臟復律去顫器(ICD) 和心臟再同步治療去顫器(CRT -D) 的推動。

市場參與者投資增加

隨著技術的進步和對自動體外心臟去顫器的需求不斷成長，市場參與者不斷增加在該領域的投資，推動未來幾年所分析市場的預期成長。微創心律管理有限公司是微創科學公司的子公司，專注於植入式心律調節器和除顫器設備的開發和商業化，以及管理心律不整的相關創新，於2021 年7 月就其1.5億美元C 輪融資簽署了最終協議。市場參與者不斷增加的投資和合作是市場擴張的動力。

自動體外顫動市場的主要參與者正在加大研發投資，以促進新產品的創造。根據飛利浦2020年年報，該公司2018年的研發費用為17.59億歐元，2019年為18.84億歐元，2020年為19.15億歐元。這種不斷增加的投資推動了市場的擴張。

細分市場洞察

產品類型見解：

從產品類型來看，全球除顫器市場分為手動體外心臟去顫器、全自動體外心臟去顫器（AED）、穿戴式心臟復律去顫器。到 2022 年，AED 細分市場將佔據重要的市場佔有率。AED 是攜帶式設備，旨在幫助心臟驟停的個人。自動體外心臟去顫器是一種能夠分析心律並提供電擊或去顫以恢復有效心律的醫療設備。

最終使用者見解

最終用戶部分分為醫院、院前、公共訪問市場、替代護理市場和家庭。由於心臟病患者在醫院接受治療的頻率較高以及醫療機構進行的手術普遍存在，因此預計醫院部門將在市場上佔據主導地位。醫院更頻繁地使用 ICD 和體外除顫器來治療心臟驟停的患者以及用於其他醫療目的。截至 2021 年 1 月，波士頓科學公司報告稱，全球已銷售約 659,000 個 ICD。與 2020 年 1 月分發的 60 萬份 ICD 相比，大幅增加了 5.9 萬份，顯示市場需求強勁。

區域見解：

北美地區在 2022 年的收入佔有率最高，成為最大的貢獻者。關鍵參與者的大量存在、提高公眾使用 AED 可用性的支持性法規以及醫療機構中外部除顫器的廣泛採用促成了這種主導地位。值得注意的是，美國心臟協會 (AHA) 等受人尊敬的組織主張實施全面的公共除顫 (PAD) 計劃。這些計劃強調 AED 的策略部署、定期維護和測試、急救人員培訓、EMS 協調和持續品質改進。

相較之下，預計未來幾年歐洲體外心臟去顫器市場將出現最快的成長。這可以歸因於完善的醫療基礎設施、大量易患心血管事件的老年人口以及關鍵行業參與者的存在。一個典型的例子是 WEINMANN Emergency Medical Technology GmbH + Co. KG，這是一家德國製造商，以其專為復甦和患者監護而設計的 MEDUCORE Standard 系列體外除顫器而聞名。這些設備供緊急醫療服務人員、軍事醫療團隊和醫院使用。

主要市場參與者

  • 皇家飛利浦公司
  • 史賽克
  • 佐爾醫療公司
  • 日本光電株式會社
  • 普羅傑蒂公司
  • 席勒公司
  • MS 威斯特伐利亞有限公司
  • 貝克森有氧運動
  • 銀線醫療科技列兵。有限公司
  • 梅迪納有限公司

可用的客製化：

全球自動體外心臟去顫器市場報告以及給定的市場資料，技術科學研究根據公司的具體需求提供客製化服務。該報告可以使用以下自訂選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 考慮學習的年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球自動體外心臟去顫器市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型（手動體外心臟去顫器、全自動體外去顫器、穿戴式心臟復律去顫器）
    • 按最終用戶（醫院、院前急救、公共服務市場、替代護理市場、家庭）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖

第 6 章：北美自動體外心臟去顫器市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲自動體外心臟去顫器市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區自動體外心臟去顫器市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲自動體外心臟去顫器市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲自動體外心臟去顫器市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非自動體外心臟去顫器
    • 沙烏地阿拉伯自動體外心臟去顫器
    • 阿拉伯聯合大公國自動體外心臟去顫器

第 11 章：市場動態

  • 動力
  • 挑戰

第 12 章：市場趨勢與發展

  • 產品發布
  • 併購
  • 最近的發展

第 13 章：全球自動體外心臟去顫器市場：SWOT 分析

第14章：競爭格局

  • 商業概覽
  • 應用程式產品
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Koninklijke Philips NV
    • Stryker
    • Zoll Medical Corporation
    • Nihon Kohden Corporation
    • ProgettiSrl
    • Schiller AG
    • MS Westfalia GmbH
    • Bexen Cardio
    • Silverline Meditech Pvt. Ltd.
    • Mediana Co., Ltd.

第 15 章：策略建議

第 16 章：關於我們與免責聲明

簡介目錄
Product Code: 4457

The Global Automated External Defibrillator Market was valued at USD 3,215.2 million in 2022 and is expected to exhibit robust growth in the forecast period, with a CAGR of 7.0% through 2028. Defibrillators, as medical devices, are utilized to administer electric shocks or pulses to the heart in order to restore a regular heartbeat. They are employed to prevent or treat abnormal, slow, or fast heart rhythms known as arrhythmias. Additionally, defibrillators can revive a heart that has suddenly ceased beating. Various designs and operational methods exist for defibrillators. Automated external defibrillators (AEDs) are widely accessible in public places and can be utilized by untrained individuals in emergency situations, potentially saving someone experiencing cardiac arrest. Other types of defibrillators, such as wearable cardioverter defibrillators (WCDs) and implanted cardioverter defibrillators (ICDs), are employed to prevent sudden death in individuals at high risk of life-threatening arrhythmias. Adjusting to having a defibrillator at home may require time and effort, making awareness of potential issues crucial.

Key Market Drivers:

Growing Incidence of Cardiovascular Diseases

Market Overview
Forecast Period2018-2028
Market Size 2022USD 1500.01 Million
Market Size 2028USD 2254.85 Million
CAGR 2023-20287.04%
Fastest Growing SegmentFully Automated External Defibrillator
Largest MarketNorth America

The prevalence of cardiovascular diseases remains a significant cause of mortality globally, despite advancements in emergency cardiac care that enhance a patient's chances of survival. Research indicates that approximately 350,000 Americans succumb to heart disease annually, with half of these fatalities occurring unexpectedly outside of medical facilities when the heart ceases to function. Sudden cardiac arrest, characterized by its abrupt onset, accounts for the majority of these untimely deaths. Ventricular fibrillation, an irregular heart rhythm disorder, is typically responsible for triggering sudden cardiac arrest. The automated external defibrillator (AED) is gaining popularity due to its ability to administer electric shocks for treating abnormal heart rhythms. These devices are designed to detect and treat two specific types of cardiac arrhythmias: pulseless ventricular tachycardia and ventricular fibrillation. In the coming years, the global market for AEDs is expected to present revenue-generating opportunities, driven by the increasing use of these devices in treating patients experiencing sudden cardiac arrest. Furthermore, the growing number of individuals dependent on smoking and alcohol consumption could contribute to prosperous market prospects.

Increase in Adoption of Advanced Defibrillator Devices

The adoption of advanced defibrillator devices has seen a significant increase. These modern devices are equipped with user-friendly interfaces and automated features, making them accessible to a wider range of healthcare professionals, including non-specialists. This accessibility has been instrumental in emergency situations, where these devices are confidently operated, improving patient care and outcomes. As healthcare spending continues to rise, both in developed and developing countries, there is a growing investment in upgrading medical equipment and technologies. In line with this, hospitals and healthcare facilities are prioritizing the implementation of advanced defibrillators to meet the unique needs of older patients and provide optimal care.

The demand for quality medical care has also been on the rise. Timely medical interventions are crucial, especially in critical situations like cardiac arrest. Defibrillators play a vital role in rapid response to life-threatening arrhythmias, significantly improving the chances of successful resuscitation and better patient outcomes. The availability and proper use of defibrillators in healthcare facilities, public spaces, and even homes are prioritized through quality care protocols, leading to higher survival rates. By promptly restoring normal heart rhythms, defibrillators contribute to better patient outcomes and reduced long-term health consequences. This focus on quality care not only enhances patient experience and satisfaction but also drives investments in advanced defibrillator technologies.

Technological advancements in healthcare have paved the way for the development of comprehensive end-to-end solutions in the defibrillator market. Favorable government initiatives, coupled with high healthcare expenditures, have created an environment conducive to innovation. Market participants are actively engaged in integrating innovative hardware and sophisticated software, expanding the scope of pre-hospital care for first responders. Notably, companies like Royal Philips have introduced remote monitoring and defibrillator solutions that enable real-time data transfer, revolutionizing pre-hospital care. Startups also play a significant role in driving market growth through their contributions to the defibrillator industry.

However, the market still faces challenges, including accessibility issues with external defibrillators. Studies have shown that the likelihood of an automated external defibrillator (AED) being nearby during a cardiac arrest is low, and there may be further restrictions on access due to closed buildings. Out-of-hospital cardiac arrest remains a significant cause of fatalities, with low survival rates. The limited use of AEDs in public settings can be attributed to concerns about legal liability, training requirements, limited access, and lack of general awareness. Nonetheless, research has unequivocally demonstrated that immediate access to an AED significantly enhances survival chances.

Strict rules and regulations also pose challenges to the defibrillator market. However, with ongoing advancements and initiatives, the industry continues to progress, aiming to overcome these obstacles and improve healthcare outcomes for patients.

Regulatory authorities established by governments worldwide enforce rigorous regulations and policies to govern the automated external defibrillators market. These measures ensure the accessibility of safe, appropriate, and affordable devices that serve their medical purpose for the public. However, these regulations can present challenges for vendors, resulting in delayed approvals and occasional product recalls that incur significant costs.

The licensing, evaluation, surveillance, and control of medical devices have become increasingly intricate for national regulatory authorities. The growing number of new products, quality concerns, and technical issues arising from rapid scientific advancements pose significant hurdles. Consequently, governments are implementing even more stringent regulations, further impacting market growth.

Key Market Trends

Advancements in Next-Generation Defibrillators

The defibrillator market is projected to experience accelerated growth, surpassing initial expectations, owing to advancements in next-generation defibrillators. Defibrillators play a crucial role in identifying and resolving device-related issues. Sudden Cardiac Arrest (SCA), a leading cause of global mortality, carries potential fatality. However, early intervention and defibrillation can effectively manage this condition. Among external defibrillators, Automated External Defibrillators (AEDs) dominate the market and are expected to witness significant expansion, driven by the increasing number of heart failure patients relying on them. The growing demand aligns with the availability of a wider range of AEDs. Currently, wearables hold a competitive edge over manual external defibrillators. Furthermore, market growth is anticipated to receive a boost from Subcutaneous Implantable Cardioverter-Defibrillators (S-ICDs), MRI-compatible Implantable Cardioverter-Defibrillators (ICDs), and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) in the upcoming years.

Increase in Investments by Market Players

With the advancement of technology and the growing demand for automated external defibrillators, market participants are consistently increasing their investment in the field, propelling the projected growth of the analyzed market in the coming years. MicroPort Cardiac Rhythm Management Limited, a subsidiary of MicroPort Scientific Corporation focused on the development and commercialization of implantable pacemaker and defibrillator equipment, along with associated innovations to manage cardiac rhythm disorders, entered into definitive agreements in July 2021 regarding its USD 150 million Series C financing. Such escalating investment and collaborations by market participants serve as drivers for the expansion of the market.

The key players in the automatic external fibrillation market are intensifying their investment in research and development to foster the creation of new products. According to Philips' annual report for 2020, the company incurred research and development expenses amounting to EUR 1,759 million in 2018, EUR 1,884 million in 2019, and EUR 1,915 million in 2020. This increasing investment fuels the expansion of the market.

Segmental Insights

Product Type Insights:

In terms of product type, the global defibrillator market is categorized into Manual External Defibrillator, Fully Automated External Defibrillator (AED), Wearable Cardioverter Defibrillator. The AED segment holds a significant market share in 2022. AEDs are portable devices designed to assist individuals in sudden cardiac arrest. An automated external defibrillator is a medical device capable of analyzing the heart's rhythm and delivering an electrical shock or defibrillation to restore an effective rhythm to the heart.

End User Insights

The end user segment is categorized into Hospitals, Pre-Hospitals, Public Access Market, Alternate Care Market, and Home. The Hospitals segment is projected to have a dominant presence in the market due to the higher frequency of cardiac patients receiving care in hospitals and the prevalence of procedures carried out in healthcare facilities. Hospitals employ ICDs and external defibrillators more frequently for the treatment of patients who have experienced sudden cardiac arrest and for other medical purposes. As of January 2021, Boston Scientific reported a worldwide distribution of approximately 659,000 ICDs. This represents a significant increase of 59,000 compared to the 600,000 ICDs distributed by January 2020, indicating a strong demand in the market.

Regional Insights:

North America accounted for the highest revenue share in 2022, making it the largest contributor. The significant presence of key players, supportive regulations to enhance the availability of public access AEDs, and the widespread adoption of external defibrillators in healthcare facilities contribute to this dominance. Notably, esteemed organizations like the American Heart Association (AHA) in the U.S. advocate for the implementation of comprehensive Public Access Defibrillation (PAD) programs. These programs emphasize strategic placement of AEDs, regular maintenance and testing, responder training, EMS coordination, and continuous quality improvement.

In contrast, Europe is projected to experience the fastest growth in the external defibrillators market in the coming years. This can be attributed to the well-established healthcare infrastructure, a sizable geriatric population susceptible to cardiovascular events, and the presence of key industry players. A prime example is WEINMANN Emergency Medical Technology GmbH + Co. KG, a German manufacturer renowned for its MEDUCORE Standard series of external defibrillators designed for resuscitation and patient monitoring. These devices are intended for use by emergency medical services personnel, military medical corps, and hospitals.

Key Market Players

  • Koninklijke Philips N.V.
  • Stryker
  • Zoll Medical Corporation
  • Nihon Kohden Corporation
  • ProgettiSrl
  • Schiller AG
  • MS Westfalia GmbH
  • Bexen Cardio
  • Silverline Meditech Pvt. Ltd.
  • Mediana Co., Ltd.

Report Scope:

In this report, the Global Automated External Defibrillator Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Automated External Defibrillator Market, By Product Type:

  • Manual External Defibrillator
  • Fully Automated External Defibrillator
  • Wearable Cardioverter Defibrillator

Automated External Defibrillator Market, By End User:

  • Hospitals
  • Pre-Hospitals
  • Public Access Market
  • Alternate Care Market
  • Home

Automated External Defibrillator Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Automated External Defibrillator Market.

Available Customizations:

Global Automated External Defibrillator Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Automated External Defibrillator Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Manual External Defibrillator, Fully Automated External Defibrillator, Wearable Cardioverter Defibrillator)
    • 5.2.2. By End User (Hospitals, Pre-Hospitals, Public Access Market, Alternate Care Market, Home)
    • 5.2.3. By Region
    • 5.2.4. By Company (2022)
  • 5.3. Market Map

6. North America Automated External Defibrillator Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Automated External Defibrillator Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Automated External Defibrillator Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Automated External Defibrillator Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By End User

7. Europe Automated External Defibrillator Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Automated External Defibrillator Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By End User
    • 7.3.2. United Kingdom Automated External Defibrillator Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By End User
    • 7.3.3. Italy Automated External Defibrillator Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By End User
    • 7.3.4. France Automated External Defibrillator Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Automated External Defibrillator Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By End User

8. Asia-Pacific Automated External Defibrillator Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Automated External Defibrillator Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Automated External Defibrillator Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Automated External Defibrillator Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Automated External Defibrillator Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Automated External Defibrillator Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By End User

9. South America Automated External Defibrillator Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Automated External Defibrillator Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Automated External Defibrillator Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Automated External Defibrillator Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By End User

10. Middle East and Africa Automated External Defibrillator Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Automated External Defibrillator Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Automated External Defibrillator Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Automated External Defibrillator Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Product Launches
  • 12.2. Mergers & Acquisitions
  • 12.3. Recent Developments

13. Global Automated External Defibrillator Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Application Offerings
  • 14.3. Recent Developments
  • 14.4. Key Personnel
  • 14.5. SWOT Analysis
    • 14.5.1. Koninklijke Philips N.V.
    • 14.5.2. Stryker
    • 14.5.3. Zoll Medical Corporation
    • 14.5.4. Nihon Kohden Corporation
    • 14.5.5. ProgettiSrl
    • 14.5.6. Schiller AG
    • 14.5.7. MS Westfalia GmbH
    • 14.5.8. Bexen Cardio
    • 14.5.9. Silverline Meditech Pvt. Ltd.
    • 14.5.10. Mediana Co., Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer